openPR Logo
Press release

Emergency of Vaccines to destroy coronavirus disease | Infectious Diseases | Read Vaccines Market 2019-2027

04-14-2020 04:01 PM CET | Health & Medicine

Press release from: Meticulous Research

Emergency of Vaccines to destroy coronavirus disease |

Vaccines represent one of the greatest achievements of science and medicine in the fight against infectious diseases. Vaccination is one of the most cost-effective public health tools to prevent infectious diseases. Significant progress has been made in expanding the coverage of vaccines globally, resulting in the prevention of more than two million deaths annually.

The growth of this market is mainly attributed to high prevalence of diseases, increasing government initiatives towards immunization, rising adoption of vaccines, technological advancement in vaccine industry, and strong pipeline for vaccines.

According to the Global Burden of Diseases and Institute for Health Metrics and Evaluation, the number of deaths caused by vaccine-preventable diseases such as tuberculosis decreased from 1.7 million in 2000 to 1.2 million in 2016. Moreover, although the incidence of Hepatitis is increasing year on year, the number of deaths caused by hepatitis B has decreased from 33.8 thousand in 2005 to 21.4 thousand in 2016. The decreasing incidence of death caused by vaccine-preventable infectious and other diseases is the evidence for the high adoption of vaccination.

Read complete research @ https://www.meticulousresearch.com/product/vaccines-market-5076/

Vaccines Market by Indication (Influenza, Rotavirus, DTP Vaccines), Route of Administration (Intramuscular, Subcutaneous, Oral), Type/Antigen (Conjugate Vaccine, Live Attenuated Vaccine), Valence (Multivalent, Monovalent Vaccines) - Global Forecast to 2027

The global vaccines market is expected to grow at a CAGR of ~5.2% from 2019 to 2027 to reach $62.2 billion by 2027.

The high prevalence of infectious diseases, increasing government initiatives towards immunization, technological advancements in the vaccine industry, and a strong pipeline for vaccines are the key factors driving steady growth in the global vaccines market. Furthermore, increasing epidemic potentials, growing focus on therapeutic vaccines, and emerging markets offer significant revenue growth opportunities for the players operating in this market.

Request free Sample report @ https://www.meticulousresearch.com/request-sample-report/cp_id=5076

Scope of the Report:

Global Vaccines Market, by Indication
Pneumococcal Disease
Influenza
DTP
Human Papilloma Virus (HPV)
Meningococcal Disease
Poliomyelitis (Polio)
MMR
Rotavirus
Hepatitis
Other Indications

(Note: Other indications include varicella, herpes zoster vaccines, chlorella, and rabies vaccines.)

Global Vaccines Market, by Route of Administration

Intramuscular (IM)
Subcutaneous (SC)
Oral
Other Routes

(Note: Other routes include intradermal (ID), transcutaneous (TC), and nasal route)

Global Vaccines Market, by Type/Antigen

Subunit & Conjugate Vaccines
Inactivated vaccines
Live Attenuated Vaccines
Toxoid vaccines
Combination Vaccines

Global Vaccines Market, by Valence

Multivalent Vaccines
Monovalent vaccines

Global Vaccines Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa

Speak to our analyst
https://www.meticulousresearch.com/speak-to-analyst/cp_id=5076

Additional Insights-

In addition to global opportunity analysis and market forecasts, the Vaccines Market study provides detailed insights on regulatory analysis, product pipeline analysis, pricing analysis, and unmet need analysis. The study also showcases competitive benchmarking for top market players, by product and geography. The competitive landscape of this study also provides market share analysis, by market players and vaccines brand.

Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2016-2019). The key players profiled in the global vaccines market are Sanofi (France), Merck & Co., Inc. (U.S.), GlaxoSmithKline plc (U.K.), Pfizer Inc. (U.S.), Johnson & Johnson (U.S.), Daiichi Sankyo Co., Ltd. (Japan), Takeda Pharmaceutical Company Limited (Japan), CSL Limited (Australia), Emergent BioSolutions Inc. (U.S.), and AstraZeneca (U.K.).

TOP 10 VACCINES MANUFACTURERS 2019 @ https://meticulousblog.org/top-10-companies-in-vaccines-market/

Key questions answered in the report-

What is Vaccines Market?
What are the market size forecasts and CAGR from the period 2019-2027?
Which are the largest and fastest growing vaccine types of the market?
What are the major drivers of the market?
What are the major restraints of the global vaccines market?
What are the major opportunities in the global market?
What are the major challenges in the global market?
Who are the major key players operating in the global vaccines market?
What are high growth countries/regions in the market?

Download Sample Report NOW !! https://www.meticulousresearch.com/download-sample-report/cp_id=5076

Contact us

Mr. Khushal Bombe
Meticulous Research
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)

About Meticulous Research

Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Emergency of Vaccines to destroy coronavirus disease | Infectious Diseases | Read Vaccines Market 2019-2027 here

News-ID: 2010334 • Views:

More Releases from Meticulous Research

The Cloud Managed Services Market is projected to reach $247.5 billion by 2030
The Cloud Managed Services Market is projected to reach $247.5 billion by 2030, growing at a robust CAGR of 14.2% from 2023 to 2030. This growth is fueled by advancements in cloud technologies, increasing demand in sectors like BFSI and healthcare, and a rising focus on customized and managed cloud services. However, challenges such as high costs, security risks, compliance issues, and limited flexibility may impact market growth. Download free
Language Learning Market Projected to Reach $124.6 Billion by 2031
Meticulous Research® recently published a report titled, "Language Learning Market by Age Group (40 years), Language (English, Mandarin, Spanish, French, German, Italian, Japanese), End User (B2C, B2B), and Geography - Global Forecast to 2031." Download sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=5561 According to the report, the language learning market is anticipated to reach $124.6 billion by 2031, growing at a CAGR of 10.7% from 2024 to 2031. Key factors fueling this growth
Oncology Information Systems Market to be Worth $4.45 Billion by 2030: Analytica …
Introduction: Meticulous Research® recently released a comprehensive report titled "Oncology Information Systems Market By Offering (Software, Services) Application (Medical, Surgical, Radiology Oncology) End User (Hospital, Diagnostic Imaging Center, Cancer Care Center) - Global Forecast to 2030." The report reveals that the oncology information systems (OIS) market is projected to reach approximately $4.45 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.4% from 2024. This growth is
IoT Sensors Market to be Worth $56.8 Billion by 2030
IoT Sensors Market to be Worth $56.8 Billion by 2030
Meticulous Research®-a leading global market research company, published a research report titled, 'IoT Sensors Market by Offering (Image Sensors, RFID Sensors, Biosensors, Humidity Sensors, Optical Sensors, Others), Technology (Wired, Wireless), Sector (Manufacturing, Retail, Consumer Electronics, Others), & Geography - Global Forecast to 2030.' According to this latest publication from Meticulous Research®, in terms of value, the IoT sensors market is projected to reach $56.8 billion by 2030, at a CAGR of

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion